JPRN-UMIN000004086已完成2 期
S-1 plus Oxaliplatin combination chemotherapy in a stop-and-go fashion for metastatic colorectal cancer - OPTISOX Study
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Medical history of severe anaphylaxis or allergia to any drug 2) Pregnant or lactating woman at any time during study. Men of the fertility hope. 3) Serious infection 4) Severe complications 5) Severe cardiac disease 6) Neuropathy 7) Severe diarrhea 8) Massive pleural or abdominal effusion 9) High grade stenosis at the primary tumor 10) Presence of peritoneal dissemination or peritoneal tuberosity assessed by image test 11) Brain metastasis 12) Double cancer 13) Prior adjuvant chemotherapy with oxaliplatin containing regimen 14) Systemic administration of corticosteroids 15) Patients who are judged inappropriate for the entry into the study by the investigator
研究者
相似试验
已完成
2 期
Treatment using Oxaliplatin and S-1 Adjuvant chemotherapy for Stage III gastric cancer trialGastric cancerJPRN-UMIN000025824Department of Surgery, Kochi Medical School75
已完成
1 期
A Phase I/II Study of S-1 and Oxaliplatin Combined With Radiation for Preoperative Locally Advanced Rectal CarcinomaColorectal CancerJPRN-UMIN000017450Japan Clinical Cancer Research Organization45
已完成
不适用
eoadjuvant chemotherapy of S-1/OXaliplatin for locally advanced Gastric cancer PIIgastric cancerJPRN-UMIN000018661Kobe City Medical Center General Hospital40
已完成
1 期
Combination chemotherapy of TS-1, oxaliplatin and irinotecan (TIROX) for unresectable gastric cancer; a phase I studygastric cancerJPRN-UMIN000030482Osaka Medical College Hospital18
已完成
2 期
Efficacy and safety of S-1 plus oxaliplatin (C-SOX) as adjuvant chemotherapy for Stage III colon cancer.Colon cancerJPRN-UMIN000012618Kyushu Study group of Clinical Cancer(KSCC)85